Europe Cranial Implants Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The Europe cranial implants market is projected to grow significantly, reaching approximately US$ 516.62 million by 2031, up from US$ 307.23 million in 2023, reflecting a compound annual growth rate (CAGR) of 6.7% during this period.

Executive Summary and Market Analysis

The market for cranial implants in Europe is divided into several key regions, including Germany, the UK, France, Italy, Spain, and the Rest of Europe. The growth of this market is primarily driven by the rising incidence of neurological disorders and traumatic brain injuries, which have led to an increased demand for cranial implants. Furthermore, advancements in medical technology have improved the precision and effectiveness of these implants, making them more appealing to healthcare providers. Increased healthcare expenditure by governments in the region also supports market expansion, alongside a growing focus on customized and patient-specific implant solutions aimed at enhancing surgical outcomes.

Market Segmentation Analysis

The Europe cranial implants market can be analyzed through various segments, including type, material, and application:

By Type: The market is categorized into parietal, frontal, occipital, temporal, and sphenoid implants. In 2023, parietal implants held the largest market share.
By Material: The segmentation includes polymethyl methacrylate, polyether ether ketone, titanium, and others, with polyether ether ketone leading the market in 2023.
By End User: The market is divided into hospitals, trauma centers, and others, with hospitals accounting for the largest share in 2023.

Market Outlook

According to the United Nations Population Division, the global geriatric population was around 600 million in 2021 and is expected to reach 2 billion by 2050. The World Health Organization (WHO) projects that by 2030, one in six people globally will be aged 60 or older, with the population in this age group increasing from 1 billion in 2020 to 1.4 billion. By 2050, the number of individuals aged 60 and above is expected to double, reaching 2.1 billion, with those aged 80 and older tripling to 426 million.

In Europe, Eurostat data indicates that over 21% of the population was aged 65 or older in 2022. The incidence of epilepsy, which increases with age, is particularly high among those aged 75 and above. Older adults are more susceptible to falls and accidents, which heightens the risk of head trauma. This demographic trend, combined with a higher prevalence of neurological diseases, is driving the demand for cranial implants. Surgical interventions are often necessary to repair skull fractures resulting from such injuries, making cranial implants crucial for restoring skull integrity and protecting the brain. Healthcare systems are increasingly focused on enhancing the quality of life for older adults, leading to greater adoption of cranial implants in trauma and reconstructive surgeries.

Country Insights

The Europe cranial implants market includes key countries such as Germany, the UK, France, Spain, Italy, and others, with Germany holding the largest market share in 2023. According to the Statistisches Bundesamt, approximately 27% of Germany's population was aged 40-60 in 2022, with those aged 65 and older constituting the next largest demographic. Reports indicate that around 270,000 individuals in Germany experience traumatic brain injuries (TBIs) annually, particularly among the elderly. Cranial implants play a vital role in treating TBIs, aiding both physical recovery and long-term neurological health. Additionally, Germany sees about 88,922 stroke cases each year, with a significant mortality rate. The number of stroke cases is expected to rise by 30% by 2035, further increasing the demand for cranial implants in treatment and rehabilitation.

Company Profiles

Key players in the Europe cranial implants market include Stryker Corp, Zimmer Biomet Holdings Inc, Integra LifeSciences Holdings Corp, OsteoMed SA, Anatomics Pty Ltd, Matrix Surgical Holdings LLC, and others. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative products to consumers.

Product Code: BMIRE00031981

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Europe Cranial Implants Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Europe Cranial Implants Market - Key Market Dynamics

5.1 Europe Cranial Implants Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increase in Prevalence of Traumatic Brain Injuries
- 5.2.2 Surge in Elderly Populations
5.3 Market Restraints
- 5.3.1 Risk of Implant Failure
5.4 Market Opportunities
- 5.4.1 Advancements in 3D Printing with Incorporation of Original Multilayer Technology
5.5 Future Trends
- 5.5.1 Customized Implants
5.6 Impact of Drivers and Restraints:

6. Europe Cranial Implants Market - Analysis

6.1 Europe Cranial Implants Market Revenue (US$ Million), 2021-2031
6.2 Europe Cranial Implants Market Forecast Analysis

7. Europe Cranial Implants Market Analysis - by Type

7.1 Parietal
- 7.1.1 Overview
- 7.1.2 Parietal: Europe Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Frontal
- 7.2.1 Overview
- 7.2.2 Frontal: Europe Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Occipital
- 7.3.1 Overview
- 7.3.2 Occipital: Europe Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Temporal
- 7.4.1 Overview
- 7.4.2 Temporal: Europe Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Sphenoid
- 7.5.1 Overview
- 7.5.2 Sphenoid: Europe Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Cranial Implants Market Analysis - by Material

8.1 Polymethyl Methacrylate
- 8.1.1 Overview
- 8.1.2 Polymethyl Methacrylate: Europe Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Polyether Ether Ketone
- 8.2.1 Overview
- 8.2.2 Polyether Ether Ketone: Europe Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Titanium
- 8.3.1 Overview
- 8.3.2 Titanium: Europe Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Others
- 8.4.1 Overview
- 8.4.2 Others: Europe Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Cranial Implants Market Analysis - by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Europe Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Trauma Centers
- 9.2.1 Overview
- 9.2.2 Trauma Centers: Europe Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Others
- 9.3.1 Overview
- 9.3.2 Others: Europe Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Cranial Implants Market - Country Analysis

10.1 Europe
- 10.1.1 Europe Cranial Implants Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 Europe Cranial Implants Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.2 Germany: Europe Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.2.1 Germany: Europe Cranial Implants Market Share - by Type
    - 10.1.1.2.2 Germany: Europe Cranial Implants Market Share - by Material
    - 10.1.1.2.3 Germany: Europe Cranial Implants Market Share - by End User
  - 10.1.1.3 United Kingdom: Europe Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.3.1 United Kingdom: Europe Cranial Implants Market Share - by Type
    - 10.1.1.3.2 United Kingdom: Europe Cranial Implants Market Share - by Material
    - 10.1.1.3.3 United Kingdom: Europe Cranial Implants Market Share - by End User
  - 10.1.1.4 France: Europe Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.4.1 France: Europe Cranial Implants Market Share - by Type
    - 10.1.1.4.2 France: Europe Cranial Implants Market Share - by Material
    - 10.1.1.4.3 France: Europe Cranial Implants Market Share - by End User
  - 10.1.1.5 Spain: Europe Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.5.1 Spain: Europe Cranial Implants Market Share - by Type
    - 10.1.1.5.2 Spain: Europe Cranial Implants Market Share - by Material
    - 10.1.1.5.3 Spain: Europe Cranial Implants Market Share - by End User
  - 10.1.1.6 Italy: Europe Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.6.1 Italy: Europe Cranial Implants Market Share - by Type
    - 10.1.1.6.2 Italy: Europe Cranial Implants Market Share - by Material
    - 10.1.1.6.3 Italy: Europe Cranial Implants Market Share - by End User
  - 10.1.1.7 Rest of Europe: Europe Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.7.1 Rest of Europe: Europe Cranial Implants Market Share - by Type
    - 10.1.1.7.2 Rest of Europe: Europe Cranial Implants Market Share - by Material
    - 10.1.1.7.3 Rest of Europe: Europe Cranial Implants Market Share - by End User

11. Industry Landscape

11.1 Overview
11.2 Mergers and Acquisitions
11.3 Product Launch
11.4 Expansions and Other Strategic Developments

12. Company Profiles

12.1 Stryker Corp
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Zimmer Biomet Holdings Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Integra LifeSciences Holdings Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 OsteoMed SA
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Anatomics Pty Ltd
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Matrix Surgical Holdings LLC
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Calavera Surgical
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Medtronic Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Xilloc Medical BV
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Johnson & Johnson
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 evonos GmbH & Co. KG
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
12.12 B Braun SE
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments
12.13 UAB Ortho Baltic
- 12.13.1 Key Facts
- 12.13.2 Business Description
- 12.13.3 Products and Services
- 12.13.4 Financial Overview
- 12.13.5 SWOT Analysis
- 12.13.6 Key Developments
12.14 3D Systems Corp
- 12.14.1 Key Facts
- 12.14.2 Business Description
- 12.14.3 Products and Services
- 12.14.4 Financial Overview
- 12.14.5 SWOT Analysis
- 12.14.6 Key Developments
12.15 GPC Medical Ltd
- 12.15.1 Key Facts
- 12.15.2 Business Description
- 12.15.3 Products and Services
- 12.15.4 Financial Overview
- 12.15.5 SWOT Analysis
- 12.15.6 Key Developments
12.16 Bioplate Inc
- 12.16.1 Key Facts
- 12.16.2 Business Description
- 12.16.3 Products and Services
- 12.16.4 Financial Overview
- 12.16.5 SWOT Analysis
- 12.16.6 Key Developments
12.17 EUROS SAS
- 12.17.1 Key Facts
- 12.17.2 Business Description
- 12.17.3 Products and Services
- 12.17.4 Financial Overview
- 12.17.5 SWOT Analysis
- 12.17.6 Key Developments
12.18 Biocomposites Ltd
- 12.18.1 Key Facts
- 12.18.2 Business Description
- 12.18.3 Products and Services
- 12.18.4 Financial Overview
- 12.18.5 SWOT Analysis
- 12.18.6 Key Developments
12.19 Medprin Biotech GmbH
- 12.19.1 Key Facts
- 12.19.2 Business Description
- 12.19.3 Products and Services
- 12.19.4 Financial Overview
- 12.19.5 SWOT Analysis
- 12.19.6 Key Developments
12.20 Kelyniam Global Inc
- 12.20.1 Key Facts
- 12.20.2 Business Description
- 12.20.3 Products and Services
- 12.20.4 Financial Overview
- 12.20.5 SWOT Analysis
- 12.20.6 Key Developments
12.21 MedCAD
- 12.21.1 Key Facts
- 12.21.2 Business Description
- 12.21.3 Products and Services
- 12.21.4 Financial Overview
- 12.21.5 SWOT Analysis
- 12.21.6 Key Developments
12.22 KLS Martin Group
- 12.22.1 Key Facts
- 12.22.2 Business Description
- 12.22.3 Products and Services
- 12.22.4 Financial Overview
- 12.22.5 SWOT Analysis
- 12.22.6 Key Developments
12.23 Longeviti Neuro Solutions LLC
- 12.23.1 Key Facts
- 12.23.2 Business Description
- 12.23.3 Products and Services
- 12.23.4 Financial Overview
- 12.23.5 SWOT Analysis
- 12.23.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms for Cranial Implant Market